19 February 2026
Lilly's Omvoh Maintains Steroid-Free Remission in Crohn's Patients for Three Years
Omvoh shows durable efficacy in Crohn's and UC, with low surgery rates and sustained symptom relief over three years, maintaining steroid-free remission in over 90% of patients.